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A long-standing question in the study of long-term
memory is how a memory trace persists for years
when the proteins that initiated the process turn
over and disappear within days. Previously, we
postulated that self-sustaining amyloidogenic oligo-
mers of cytoplasmic polyadenylation element-
binding protein (CPEB) provide a mechanism for
the maintenance of activity-dependent synaptic
changes and, thus, the persistence of memory.
Here, we found that theDrosophilaCPEBOrb2 forms
amyloid-like oligomers, and oligomers are enriched
in the synapticmembrane fraction. Of the two protein
isoforms of Orb2, the amyloid-like oligomer forma-
tion is dependent on the Orb2A form. A point muta-
tion in the prion-like domain of Orb2A, which reduced
amyloid-like oligomerization of Orb2, did not inter-
fere with learning or memory persisting up to 24 hr.
However the mutant flies failed to stabilize memory
beyond 48 hr. These results support the idea that
amyloid-like oligomers of neuronal CPEB are critical
for the persistence of long-term memory.
INTRODUCTION
Learning changes the efficacy and number of synaptic connec-
tions. Memory is the maintenance of that altered state over
time. Synaptic modification is likely to include both quantitative
and qualitative changes in local protein composition. However,
this model of memory raises a fundamental question that
remains unanswered: how does the altered protein composition
of a synapse persist for years when the molecules that initiated
the process should disappear within days (Crick, 1984; Lisman,
1994; Lynch and Baudry, 1984)?
The protein composition of a synapse can be altered in several
ways including synthesis of new proteins (Steward and Schu-man, 2001). Local synthesis of new proteins at the synapse
has been shown to be essential for stabilizing the functional
changes and physical growth of the activated synapse (Martin
et al., 2000; Sutton and Schuman, 2006). Previously, a family
of RNA-binding proteins, known as cytoplasmic polyadenylation
element-binding proteins (CPEBs), were identified as regulators
of activity-dependent protein synthesis at the synapse (Alarcon
et al., 2004; Atkins et al., 2004; Huang et al., 2002, 2003, 2006;
Kundel et al., 2009; Si et al., 2003a; Wells et al., 2001; Wu
et al., 1998). In the sea snail Aplysia, a neuron-specific variant
of CPEB, ApCPEB, is required not for the initial changes in
synaptic efficacy or growth following serotonin stimulation but
for the maintenance of these changes beyond 24 hr (Miniaci
et al., 2008; Si et al., 2003a, 2010). In Drosophila, reduction in
Orb2, a member of the CPEB protein family, does not affect
short-term memory (<3 hr) but does prevent the memories
from persisting beyond 12 hr (Keleman et al., 2007). In mice,
deletion of the CPEB-1 gene reduces long-term potentiation
evoked by theta-burst stimulation (Alarcon et al., 2004) and
growth-hormone application (Zearfoss et al., 2008). Together,
these observations suggest that CPEBs play a role in stabilizing
activity-dependent changes in synaptic efficacy. However, how
CPEB-dependent changes in molecular composition of the
synapse persist over time is unknown.
Previously, based on the self-sustaining amyloidogenic (prion-
like) properties of Aplysia CPEB, we hypothesized that the
activity-dependent conversion of CPEB to the amyloidogenic
state provides a self-sustaining mechanism for the persistent
change in molecular composition of the synapse and thereby
persistence of memory (Heinrich and Lindquist, 2011; Si et al.,
2003a, 2010). Consistent with this idea, in Aplysia sensory
neurons ApCPEB forms amyloidogenic aggregates when over-
expressed, and the number of aggregates increases following
stimulation with serotonin (Si et al., 2010). Moreover, an antibody
that recognizes oligomeric ApCPEB selectively blocks the
persistence of long-term facilitation of the sensory-motor neuron
synapse beyond 24 hr (Si et al., 2010). However, the central
question of whether such conversion of neuronal CPEB to the
amyloid-like state is necessary for the persistence of memoryCell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc. 515
remains unanswered. To address the behavioral significance of
the amyloid-like state of CPEB, we turned to Drosophila Orb2.
Drosophila Orb2 protein carry a prion-like domain (Figure S1A
available online) (Si et al., 2003b) and target synaptic growth-
related proteins, suggesting that Orb2 is not only structurally
but also functionally similar to ApCPEB (Mastushita-Sakai
et al., 2010).
In this paper, we asked two specific questions. First, does the
Orb2 protein form amyloid-like oligomers in the adult Drosophila
brain in an activity-dependent manner? Second, is this oligo-
merization necessary for long-term memory? We find that
Drosophila Orb2 forms stable SDS-resistant, amyloid-like oligo-
mers upon neuronal stimulation, and Orb2 mutant defective in
activity-dependent oligomerization is specifically impaired in
forming stable long-termmemories. These observations support
the hypothesis that self-sustaining amyloid-like conversion of
neuronal CPEB is involved in the persistence of memory.
RESULTS
Orb2 Exists as Monomer and Amyloid-like Oligomer
in the Adult Fly Brain
Previously, in Aplysia we observed two forms of neuronal CPEB:
an abundant monomer and a rarer SDS-resistant oligomer that
was detectable only after immunopurification (Si et al., 2003b,
2010). Similarly, in Drosophila two size classes of Orb2 proteins
were observed only upon immunoprecipitation of tyramine-
stimulated (please see Figure 2 for detail of tyramine stimulation)
head extracts: an 82 kDamonomer and a high-molecular-weight
species migrating between 160 and 420 kDa (Figures 1A and S1
for antibody specificity). This high-molecular-weight species
contains Orb2 because it is absent in orb2 null orOrb2 RNAi flies
(Figures 1A and 1B) and reappears following rescue with Orb2
genomic fragment (Figures 1C and S1B). In addition, multiple
antibodies against Orb2 (Figure S1C) recognize the high-molec-
ular-weight form (Figures 1A and 1B). Immunoprecipitation per
se did not induce the high-molecular-weight form because
immunopurification from increasing amounts of body extract
(Figure 1D) did not lead to a corresponding increase in the
high-molecular-weight Orb2. Additionally, the smaller form did
not arise from dissociation of the high-molecular-weight species
because fractionation of Orb2 immunoprecipitates in a high-salt
sucrose gradient prior to boiling and SDS treatment still revealed
two distinct peaks of Orb2: one distributed around 80–150 kDa
and another around 670 kDa (Figure 1E). These results are
consistent with the coexistence of two distinct size classes of
Orb2 in vivo.
Treatment of Orb2 immunoprecipitate with phosphatase or
N-glycosidase (PGNaseF) did not change Orb2 mobility in
SDS-PAGE (Figure 1F), and antibodies against ubiquitin, sumo,
or acetyl groups recognized neither the high- nor the low-molec-
ular-weight Orb2 (data not shown). These results suggest that
the higher-molecular-weight form is not due to phosphorylation,
N-glycosylation, ubiquitination, sumoylation, or acetylation (data
not shown). In fact, the high-molecular-weight Orb2 species is
resistant to all the following treatments: RNaseA and high salt
(Figure 1E), detergents such as 1%Triton X-100 and sodium
deoxycholate (Figure 1F, +Detergents lane), denaturants 6M516 Cell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc.urea or 6M guanidine hydrochloride (Figure 1F), and subsequent
10 min boiling in the presence of 10% SDS and 10 mM DTT
(Figure 1F), suggesting that the high-molecular-weight Orb2
protein is not due to association with other proteins or mRNA.
Purified recombinant Orb2 proteins also form heat-stable SDS-
resistant oligomers in 6M guanidine hydrochloride that are
similar in size to endogenous Orb2 oligomers (Figure 1G, also
see Figure 3 for detail of Orb2A and Orb2B) and after 4 hr in
1M urea form large amyloid-like fibers (Figure 1H). We therefore
conclude that the high-molecular-weight species are formed by
self-assembly of the Orb2 proteins into heat- and SDS-resistant
amyloid-like structures. Henceforth the high-molecular-weight
form is referred to as oligomeric Orb2, and the low-molecular-
weight form as monomeric Orb2.
Stimulation of the Fly Brain Increases Amyloid-like
Oligomer
If Orb2 is an activity-dependent regulator of protein synthesis,
we reasoned that neuronal stimulation may alter the level of
oligomeric Orb2. To test this possibility, we used the thermo-
sensitive dTrpA1 channel (Hamada et al., 2008) to depolarize
Kenyon cells of the mushroom body, a structure known to be
involved in memory formation in Drosophila (Berry et al., 2008;
Heisenberg, 2003). Flies with a single copy ofUAS-dTrpA1 under
mushroom body drivers C747-Gal4 and MB247-Gal4 showed
no significant change in the level of the monomer (Figure S1D)
but had 4- to 5-fold more of oligomeric Orb2 at 29C compared
to 22C (Figures 2A, 2C, and S1E). This increase required
both UAS-dTrpA1 and Gal4 transgene (Figure 2A). In contrast,
stimulating glutamatergic neurons outside the mushroom body
caused no change in either form of Orb2 (Figures 2C and S1F)
even though the Gal4 driver (OK371) (Mahr and Aberle, 2006)
is expressed in a similar number of neurons. These results
suggest that stimulation of mushroom body neurons increases
the amount of oligomeric Orb2.
In Drosophila, the neurotransmitters octopamine and dopa-
mine are known to regulate memory formation in the mushroom
body (Aso et al., 2010; Kim et al., 2007; Krashes et al., 2009;
Nisimura et al., 2005; Schwaerzel et al., 2003; Tempel et al.,
1984; Unoki et al., 2005). To test whether activation of these
neuromodulatory pathways can alter Orb2 levels, the tempera-
ture-sensitive dTrpA1 channel was expressed in either tyrami-
nergic/octopaminergic neurons or dopaminergic/serotonergic
neurons using the drivers Tdc2-Gal4 and Ddc-Gal4, respec-
tively. Exposure to 29C doubled the amount of oligomeric
Orb2 within an hour (Figures 2B and 2C). We also stimulated
the neuromodulatory pathways by feeding wild-type flies
biogenic amines and observed a 7- to 8-fold increase in oligo-
meric Orb2 protein upon exposure to dopamine, octopamine,
and tyramine but not serotonin (Figures 2D, 2E and S1G). This
increase occurred within 2 hr, peaked around 4 hr, and persisted
up to 24 hr (Figure 2F). The increase was observed only in the
head but not in the body (Figure 1D), suggesting that oligomeric
Orb2 is induced upon activation of the mushroom body directly
or via dopamine/tyramine/octopamine-responsive neurons.
These results are similar to what we observed in Aplysia, where
stimulation with the neurotransmitter serotonin increased oligo-
meric Aplysia CPEB protein (Si et al., 2003a, 2010).
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Figure 1. Orb2 Has a Monomeric and Amyloid-like Oligomeric Form
(A) Immunoprecipitation-western analysis of Orb2 from wild-type (orb2+/+) or orb2 null mutant (orb2/) head extracts with anti-Orb2 antibodies. The heat- and
SDS-resistant high-molecular-weight Orb2-immunoreactive bands are indicated as oligomer. The number in parentheses indicates the Orb2 antibody used.
(B) The oligomers are absent in adult fly heads expressing Orb2RNAi under the pan-neuronal Elav-Gal4 driver (Elav-Gal4:Orb2-RNAi).
(C) A genomic rescue construct encompassing the Orb2 locus, attp2>pattB-Orb2, restores the oligomers in orb2 null flies.
(D) The oligomer is not detected in extracts prepared from the body. Orb2 was immunoprecipitated from 1.5 mg of head extracts or 1.5 mg (13), 3.0 mg (23),
or 6 mg (43) of body extracts.
(E) The Orb2 protein exists in two distinct size classes in the adult brain. BSA (67 kDa), aldolase (150 kDa), and thyroglobulin (670 kDa) serve as molecular weight
markers in the gradients.
(F) The high-molecular-weight Orb2 is not due to posttranslational modifications or association with other protein or mRNA.
(G) Recombinant Orb2 forms oligomers that are similar in size to the endogenous Orb2 oligomer. Orb2A and Orb2B purified in 6 M guanidine hydrochloride were
first filtered to remove any pre-existing higher-order structure. The filtrate was diluted 6-fold in 1 M urea and compared with urea-treated (IP+1MUrea) or
untreated (IP) Orb2 immunoprecipitate. The upper box indicates a higher exposure of the lower boxed region of the same blot.
(H) Orb2A and Orb2B form amyloid-like fibers in vitro. Electron microscopy of both purified recombinant proteins shows electron-dense, amyloid-like fibers.
See also Figure S1.
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Figure 2. Neuronal Stimulation Induces Orb2 Oligomerization, and Oligomers Are Enriched in the Synaptic Membrane Fraction
(A) Stimulation of mushroom body neurons increases the amount of oligomeric Orb2. The temperature-sensitive dTrpA1 channel depolarizes and thereby
activates neurons at temperatures >25C (Hamada et al., 2008). The representative immuno-westerns shown in all figures were overexposed to ensure the
detection of all immunoreactive bands. For quantification, lower exposures were used to avoid signal saturation.
(B) Stimulation of dopaminergic/serotonergic neurons (Ddc-Gal4:UAS-dTrpA1) or tyraminergic/octopaminergic neurons (Tdc2-Gal4:UAS-dTrpA1) increases the
amount of oligomeric Orb2. A higher exposure of oligomeric Orb2 is shown at the top, marked as ‘‘Long.’’
(C) Quantification of the dTrpA1-expressing samples. The ratio of the high-molecular-weight protein at 29C to that at 22C is expressed as mean-fold
increase ± standard error of the mean (SEM): C747-Gal4:UAS-dTrpA1, 4.9 ± 1.8; MB247-Gal4:UAS-TrpA1, 4.5 ± 1.4; OK371-Gal4:UAS-dTrpA1, 0.8 ± 0.37;
Tdc2-Gal4:UAS-dTrpA1, 2.0 ± 0.53; and Ddc-Gal4:UAS-dTrpA1, 2.1 ± 0.35. The * indicates statistical significance p < 0.05 (t test), and n indicates number of
independent experiments. Each experiment included a control sample and the fold change in each experiment was measured independently. A ratio of 1 (no
induction) is indicated by a dashed line.
(D) Stimulation with tyramine, dopamine, and octopamine increases the amount of high-molecular-weight Orb2. The flies were exposed to the neurotransmitters
and kept in indicated neurotransmitter for 24 hr.
(E) Quantification of the neurotransmitter-treated samples; mean-fold increase ± SEM: tyramine, 7.4 ± 2.1; octopamine, 5.9 ± 2.3; dopamine: 9.9 ± 3.1, p < 0.05;
serotonin, 2.0 ± 0.8, p > 0.05 (t test).
(F) Time course of tyramine-mediated induction of oligomeric Orb2. A band corresponding to the size of Orb2A is marked with an arrow.
(G) Low level of monomeric Orb2 protein is present in synaptic fraction.
(H) Oligomeric Orb2 is enriched in the synaptic membrane fraction.
(I) The Orb2 oligomers in the synaptic membrane fraction are stable in 6 M urea.
The arrows in (G) and (H) indicate the position of Orb2A protein. See also Figures S1 and S2.
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TheOrb2Oligomers AreEnriched in theSynaptic Region
Our model posits that oligomeric Orb2 proteins act as a synaptic
mark, conferring temporal and spatial restriction to the activity-
dependent synaptic changes. Thus, we sought to localize the
monomeric and oligomeric forms of Orb2 within the fly nervous
system. Tissue-specific RNAi indicated that in the adult head,
neurons are the primary cell type expressing Orb2 (Figure S2A).
To determine the neuroanatomical distribution of Orb2, we intro-
duced an enhanced green fluorescent protein (EGFP)-tagged
genomic rescue construct (see Figure S1B for rescue construct)
into the orb2 null background. Orb2 expression was readily
detectable in soma throughout the brain including the mush-
room body (Figures S2B–S2D). In live brain imaging, low but
EGFP-specific signals were observed in the synaptic-neuropil
region surrounding the mushroom body but not in the antennal
lobe or subesophageal ganglia (Figure S2C). To determine the
subcellular distribution of Orb2 proteins, we prepared synapto-
some from 3 ml of tyramine-stimulated wild-type adult fly
heads and separated the membranes from the soluble fraction
(Figures S2E and S2F). The SDS-resistant oligomeric Orb2
was specifically enriched in the detergent-extracted synaptic
membrane fraction (Figures 2G and 2H). This enrichment was
in striking contrast to monomeric Orb2 whose prevalence
actually decreased in the synaptosome fractions (Figure 2G).
Notably, these oligomers are stable after boiling in 6M urea
(Figure 2I) and detectable without immunoprecipitation, sug-
gesting a native amyloid-like state of Orb2. Taken together,
the live brain imaging and biochemical fractionation suggest
that the majority of monomeric Orb2 is present in neuronal cell
bodies, whereas SDS-resistant oligomeric Orb2 is enriched in
the synaptic region.
The Rare Orb2A Isoform Is Critical for Orb2
Oligomerization
What is the composition of the Orb2 oligomer? The Orb2 locus
encodes six protein isoforms (based on Flybase modENCODE
data), of which two isoforms, Orb2A and Orb2B, are CPEB
homologs (Figures 3A and S1B for detail) (Keleman et al.,
2007; Mastushita-Sakai et al., 2010). The short Orb2A form
differs from the long Orb2B form in the number of amino acids
leading the N-terminal prion-like domain: 8 amino acids for
Orb2A and 162 amino acids for Orb2B (Figures S1A and 3A).
Does this domain organization have any consequence with
respect to Orb2 oligomerization? In flies, exogenous Or-
b2AEGFP but not Orb2BEGFP formed fluorescent puncta in
neurons (Figure 3A). These puncta probably represent
assembly of higher-order oligomers detectable in SDS-PAGE
of fly head extracts (Figures 3B and S3A) and in sucrose
gradient fractionation (Figure S3B). These differences are
inherent to the two isoforms because as in neurons, in S2 cells,
only Orb2A formed large aggregates and fluorescent puncta
(Figures S3C and S3D), even though both Orb2A and Orb2B
protein formed SDS-resistant oligomers (Figure S3C). Addition-
ally, fluorescence resonance energy transfer (FRET) and
fluorescence recovery after photobleaching (FRAP) analysis
revealed that Orb2A aggregates are more tightly assembled
(Figures S3E–S3G). FRAP analysis also revealed that Orb2A
puncta are more stable than Orb2B and other DrosophilaQ-rich RNA-binding proteins and simple polyQ aggregates
(Figures S3F and S3G). Similarly, only Orb2A formed puncta
in stimulated Aplysia sensory neurons (Si et al., 2010). These
observations imply that Orb2A is more efficient at forming
stable self-assembled oligomers. Indeed, recombinant Orb2A
monomers obtained by passing purified proteins through a
100 kDa filter to remove all pre-existing aggregates formed
oligomers in 6M guanidine hydrochloride more readily than
Orb2B monomers did (% of total protein in oligomers: Orb2A:
31.8 ± 5.2, n = 6, Orb2B, 3.3 ± 0.6, n = 3, p = 0.008)
(Figure 3C).
The robust capacity of Orb2A to assemble into oligomers
suggests that expression of the Orb2A isoform may be critical
for controlling the oligomerization of Orb2 in neurons. Notably,
the 82 kDa Orb2 protein that we primarily see in western blots
and in immunoprecipitation corresponds to the Orb2B form
(Mastushita-Sakai et al., 2010). Further, we have observed
a much less abundant 64 kDa protein corresponding to the
size of Orb2A (Figures 2F, 2H, and 2I, arrow), although, in the
absence of Orb2A-specific antibodies, we could not distinguish
Orb2A from breakdown products of Orb2B. Therefore, we
asked whether and where endogenous Orb2A protein is ex-
pressed by introducing an EGFP-tagged genomic transgene
(pCasper-Orb2AEGFP) that spans the Orb2A exon but lacks all
Orb2B and other Orb2 isoform-specific exons (Figure 3D). In
the pCasper-Orb2AEGFP flies, the level of Orb2A mRNA was
similar to that of wild-type flies (Figure S4A), and the level of
monomeric Orb2B protein was also not altered (Figure S4B). In
live imaging experiments, Orb2AEGFP expression was observed
all over the brain (Figure 3D, middle panel). However, compared
to the genomic transgene expressing both isoforms, Orb2A-
specific signals were sparse and 100-fold less prevalent
(Figure 3D, bottom panel). The Orb2AEGFP formed SDS-resis-
tant oligomers (Figure 4A) and was only detected in head but
not in body extract (Figure 4B, right panel). The low level of
Orb2A-specific signal is not an artifact of the genomic fragment
because the amount of monomeric Orb2AEGFP was similar to
that of the genomic fragment expressing both isoforms (Fig-
ure 4B, left panel). These observations suggest that the readily
oligomerizing isoform, Orb2A, is a low abundant protein in the
adult brain.
One possibility is that the limited availability of Orb2A may
serve to seed regulated oligomerization of Orb2B. To test this
model, we first asked whether they can hetero-oligomerize.
We found that HA-tagged Orb2B and EGFP-tagged Orb2A
coimmunoprecipitated as RNaseA and SDS-resistant hetero-
oligomers when expressed in S2 cells (Figure 4C). Similarly in
the adult, an Orb2B-specific antibody (Figure S4C) recognized
the oligomeric Orb2 obtained from wild-type flies (Figure 4D,
left panel). Next we determined whether Orb2A is required for
oligomerization of Orb2B by rescuing orb2 null flies with
a genomic construct lacking theOrb2A-specific exon (Figure 4E).
In these flies, oligomeric Orb2 was barely detectable (Figures 4G
and S4E) even though the level of monomeric Orb2B was similar
to wild-type (Figure 4F). Together, these data suggest that
endogenous oligomers are composed of Orb2A and Orb2B,
but Orb2A is critical for Orb2 oligomer formation in the adult
brain.Cell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc. 519
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Figure 3. Orb2A Is Expressed at Low Levels in a Subset of Neurons and Oligomerizes Efficiently
(A) Orb2A forms fluorescent puncta in the adult Drosophila neuron. Upper panel shows the location of the prion-like domain in Orb2A and B. The EGFP-tagged
Orb2A or Orb2B was expressed from R19H07-Gal4 driver in a small number of neurons in the central complex for ease of visualization. Scale bar, 10 mm.
(B) Orb2A formed more SDS-resistant oligomers than Orb2B when overexpressed as C-terminal HA-tagged proteins in the adult head. The top panel shows
a higher exposure of the oligomeric region of the same blot. The anti-HA antibody did not immunoprecipitate the high-molecular-weight Orb2.
(C) The recombinant Orb2A forms heat- and SDS-resistant oligomers more efficiently than Orb2B. The amount of oligomer with respect to total protein
is quantified on the right. In Orb2A (n = 6), 31.8% ± 5.2% of the protein form oligomer, whereas in Orb2B (n = 3), 3.3% ± 0.6% of the protein form oligomer, t test,
p = 0.008. Data are represented as mean ± SEM.
(D) Top panel: The pattB-Orb2EGFP represents an 18.7 kb wild-type genomic fragment that excludes the Orb2E-I exons, and the pCasper-Orb2AEGFP
represents an 8.27 kb fragment that excludes the Orb2B- and Orb2E-I-specific exons (please see Extended Experimental Procedures). The EGFP is fused in-
frame in theC-terminal end.Middle panel: Sum of two center slices for a brain expressing Orb2AEGFP (pCasper-Orb2AEGFP) andOrb2EGFP (pattB-Orb2EGFP).
Scale bar, 50 um. Bottom panel: The relative levels of Orb2EGFP and Orb2AEGFP in the cell body and synaptic-neuropil region (please see Extended
Experimental Procedures for details). Data are represented as mean fold increase ± SEM. Fluorescence is expressed in arbitrary units.
See also Figure S3.A Screen to Identify Orb2A Mutants with Reduced
Oligomerization Capacity
Is oligomeric Orb2 required for memories? One way to address
this question is to selectively disrupt oligomerization of Orb2.
Removal of the Q-rich 80 amino acids in the prion-like domain
common to both Orb2A and Orb2B (D80QOrb2) reduces520 Cell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc.oligomerization (Figure 5A) and impairs long-term memory (Ke-
leman et al., 2007), but this deletion also significantly reduces
Orb2 protein levels (Figure 5A). We decided to take advantage
of the observation that Orb2A is critical for overall oligomeriza-
tion of Orb2 and sought to generate a mutant that specifically
disrupts this ability of Orb2A. Interestingly, deletion of the
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Figure 4. Orb2A Is Critical for Orb2 Oligomerization
(A) Orb2AEGFP has a monomeric and an oligomeric form. ‘‘Low’’ and ‘‘High’’ indicate lower and higher exposures of the same blot.
(B) Left panel: Low level of Orb2AEGFP is also expressed from the full-length Orb2 genomic construct (Orb2EGFP). Right panel: Orb2A is not detected when
immunoprecipitated from the same amount of the total body extract. The * indicates a likely degradation product of Orb2BEGFP in the body.
(C) Orb2B and Orb2A can hetero-oligomerize in presence of detergent and high salt. Orb2B immunoprecipitate contains both monomeric and oligomeric Orb2A,
albeit the amount of the oligomer is low. The bottom panels serve as loading control.
(D) Endogenous oligomers contain Orb2B. Orb2 immunoprecipitate probed either specifically for Orb2B (left panel, Ab402) or both forms of Orb2 (right panel,
Ab273).
(E) The schematic of the wild-type (pattB-Orb2) and Orb2A-deleted (pattB-Orb2DA) genomic rescue construct. In Orb2DA, an EGFP-Kanamycin cassette was
inserted in the exon 1 that removes the start ATG codon ofOrb2A and introduces a stop codon. Bottom panel: A genomic PCR spanning theOrb2A-specific exon
shows the insertion of the EGFP-Kanamycin cassette. The insertion has also been verified by sequencing.
(F) The amount of Orb2B protein is not significantly altered in Orb2DA fly heads. Tubulin serves as loading control.
(G) Deletion of the Orb2A-specific exon reduces Orb2 oligomerization. The orb2 null flies carrying wild-type and EGFP-tagged wild-type genomic rescue
construct had both monomeric and oligomeric Orb2. As expected in the EGFP-tagged construct, there was a shift in molecular weight. No oligomeric Orb2 was
detected in the Dorb2:pattB-Orb2DA fly heads.
See also Figures S3 and S4.
Cell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc. 521
A B
C
E
D
Figure 5. Screen for Orb2A Mutations that Affect Oligomerization
(A) Deletion of Q-rich 80aa reduces both the monomeric Orb2B and the oligomeric Orb2. Top panel: a schematic representation of wild-type and D80QOrb2
genomic locus. Bottom left panel: Orb2 was immunoprecipitated from the same amount of wild-type orD80QOrb2 fly head extracts. Right panel: To compensate
for low Orb2 protein level in D80QOrb2 flies, 1.5 mg (13), 4.5 mg (33), or 9 mg (63) of total head lysates were used.
(B) The N-terminal 8 amino acids of Orb2A are critical for efficient oligomerization in S2 cells. Representative images of the EGFP-tagged wild-type Orb2A and
Orb2A lacking the N-terminal 8 amino acids (D8Orb2A), 80 amino acids (D80QOrb2A), or 88 amino acids (D88QOrb2A) or just the first 8 amino acids (Orb2A8) or
88 amino acids (Orb2A88) of Orb2A. Scale bar, 5 um.
(C) Schematic representation of the oligomerization-deficient screen in S2 cells.
(D) The mutated residues in the first 160 amino acids that affected puncta formation. The red indicates mutation in the 5th residue, and the mutations in the first 8
amino acids are indicated with red and green. Bottom panel: conservation in the first 8 amino acids of Orb2A among different Drosophila species.
(E) Conversion of phenylalanine (F) to tyrosine (Y) in the 5th position affects Orb2A puncta formation. Representative images of the EGFP-tagged Orb2A and
Orb2AF5Y 16 hr post-transfection. Unlike Orb2A, in Orb2AF5Y, 42% of the cells had diffuse fluorescence, 47% of cells had diffuse fluorescence with few small
puncta, and 11% of the cells had large puncta.
See also Figures S4 and S5.unique first 8 amino acids of Orb2A (D8Orb2A and D88Orb2A),
but not the common Q-rich domain (D80QOrb2), reduced
puncta formation in S2 cells (Figures 5B and S4F). However,522 Cell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc.in FRAP analysis, puncta formed by D80QOrb2A were four
times less stable than Orb2A puncta (fraction mobile ± standard
error of the mean [SEM]: Orb2A: 0.170 ± 0.012, n = 9;
D80QOrb2A: 0.808 ± 0.15, n = 22), which is consistent with the
observation that removal of this region reduces the amount of
SDS-resistant oligomers in the adult brain (Figure 5A). The
8 amino acids of Orb2A by themselves (Figure 5B, Orb2A8)
did not form any puncta, whereas the first 88 amino acids (Fig-
ure 5B,Orb2A88) formed large, stable puncta (fraction mobile ±
SEM: 0.14 ± 0.05, n = 15). These results suggest that the
N-terminal 8 amino acids of Orb2A catalyze oligomerization,
whereas the Q-rich 80 amino acids common to both isoforms
represent the oligomerization substrate. From these and other
studies (Figures 5 and S3), we established that S2 cells are
a viable system for monitoring Orb2A oligomerization. Using
error-prone PCR, we mutagenized the N-terminal 160 amino
acids of Orb2A that encompass the entire prion-like domain
and identified clones that exhibited diffuse fluorescence or
formed fewer fluorescent puncta in S2 cells (Figure 5C). Interest-
ingly, 7 out of 13 clones identified from this unbiased screen
had mutations within the first 8 amino acids that are unique to
Orb2A and critical for efficient oligomerization of Orb2A (Figures
5D and S5A).
A Point Mutation Specific to Orb2A, F5 > Y5, Reduces
Amyloid-like Oligomerization
A conserved phenylalanine residue in the 5th position was
changed in three independent clones (Figure 5D), suggesting
that this amino acid plays a critical role in Orb2A oligomerization.
Of the mutants, the phenylalanine to tyrosine (Orb2AF5Y) muta-
tion exhibited the most diffuse fluorescence (Figure 5E) even
though the stability and steady-state levels were similar to
control (Figures 6A and 6B). In FRAP analysis, the recovery of
Orb2AF5Y puncta was three times greater than that of Orb2A
puncta, suggesting that the mutant puncta are more dynamic
(Figure 6C). Additionally in FRET (Figure 6D) and HOMO-FRET
(Figure S5B), Orb2AF5Y had a lower mean FRET efficiency and
exhibited greater variation, suggesting that the mutant aggre-
gates are nonhomogenous in nature. Coexpression of Orb2AF5Y
did not prevent Orb2A oligomerization and exhibited even lower
FRET efficiency, further suggesting that the packing of Orb2AF5Y
is different from that of Orb2A (Figure 6D). Consistent with these
data is the observation that recombinant Orb2AF5Y also formed
oligomers poorly (Figure 6E) and showed a huge variation in olig-
omer formation (% of total protein in oligomer: Orb2A, 31.8 ±
5.2, Orb2AF5Y 25.9 ± 11, n = 4, p > 0.05). Similarly, in the adult
brain, EGFP-tagged Orb2AF5Y formed smaller puncta (Fig-
ure S5C) and lower amounts of SDS-resistant oligomers (Fig-
ure S5D). The F5Y mutation did not, however, disrupt other
properties of Orb2A, such as binding to target mRNA (Figure 6F)
and other adult brain proteins (Figure 6G). However, we cannot
rule out the possibility that the Orb2AF5Y mutation has altered
some other properties, such as interactions with yet unidentified
factors.
In order to measure the effect of the F5Y mutation on activity-
induced Orb2 oligomerization, we made transgenic flies ex-
pressing Orb2AF5Y within the context of the rescuing genomic
fragment in orb2 null background and stimulated them with
10 mM tyramine. F5Y mutant flies had 5-fold less oligomeric
Orb2 2 hr after treatment (Figure 7B), even though there was
no change in the level of monomeric Orb2B protein prior to (Fig-ure 7A) or after (Figure 7B) stimulation. These results suggest
that the Orb2AF5Y mutation specifically alters the ability of
Orb2 to form SDS-resistant amyloid-like oligomers and offers
the opportunity to examine the consequences on long-term
memory.
Orb2AF5Y Mutants Are Specifically Impaired in Forming
Long-Lasting Memory
To address whether alterations in Orb2 oligomerization affect
memory formation, we assayed the male courtship suppres-
sion memory. In this paradigm, a male fly learns to suppress
its courtship behavior upon exposure to an unreceptive, mated
female (Siegel and Hall, 1979). Repeated exposure of the male
to the unreceptive female produces learned courtship sup-
pression in the male that can persist for days (Figures S6A–
S6C and Tables S1 and S2) (McBride et al., 1999). This
memory is acutely dependent on Orb2 (Keleman et al., 2007)
because in D80Qorb2/D80Qorb2 and Dorb2/D80Qorb2 flies
it did not last 24 hr, and in Dorb2/+ flies it decayed by 48 hr
(Figures S6A–S6C and Tables S1 and S2). Male flies carrying
two copies of the wild-type Orb2 genomic rescue construct
(Dorb2:attP2>pattB-Orb2) or F5Y point-mutated construct
(Dorb2:attP2>pattB-Orb2F5Y) in the orb2 null background did
not display any deficit in their ability to court mated female
flies (Table S2). Following spaced training, Dorb2:attP2>
pattB-Orb2 male flies had a memory score similar to that of
wild-type CantonS flies at all times assayed (Figure 7C and
Tables S1 and S2). However, in Dorb2:attP2>pattB-Orb2F5Y
male flies, memory began to decay after 36 hr, and by
48–60 hr, there was no measurable memory (Figure 7C and
Table S1). We conclude from these results that the Orb2AF5Y
mutation selectively interferes with the long-term persistence
of memory.
How general is the effect of F5Y mutation on long-term
memory? To answer this question, we used the associative
olfactory-reward learning paradigm in which flies learn to asso-
ciate sucrose as a food reward with a particular odor. A single
training session of 2 min is sufficient to produce stable memory
lasting for days (Figure 7D) (Colomb et al., 2009; Krashes and
Waddell, 2008; Tempel et al., 1983). Orb2 is required for this
memory because by 24 hr the Dorb2/+ and D80Qorb2 flies
had a memory score lower than that of wild-type flies (Figures
S7A–S7C and Tables S1 and S3), and the deficit in Dorb2/+ flies
was rescued by both Orb2A and Orb2B cDNAs (Figure S7A)
expressed from drl-Gal4 driver (drl-Gal4:UAS-Orb2EGFP;
Dorb2/+), which drives expression in a number of neurons
including the mushroom body (Figure S7B). Additionally, consti-
tutive expression of neuronal Orb2RNAi from the drl-Gal4 driver
(drl-Gal4-UAS-Orb2RNAi) also resulted in a memory deficit at
24 hr but not in learning or short-term memory (Figure S7D and
Table S3). Similar results were obtained by using the Gal4-
Gal80ts system to induce the Orb2RNAi after the flies reached
the adult stage (McGuire et al., 2004) (Figure S7E and Table
S2). The olfactory acuity and preference for sucrose of Orb2F5Y
mutants were similar to those of wild-type flies (Table S3).
Surprisingly, flies expressing the F5Y point mutation did not
exhibit a memory deficit at 24 hr; however, by 48 hr, the Orb2F5Y
mutant had a lower memory score than that of wild-type flies orCell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc. 523
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Figure 6. Orb2AF5Y Mutation Selectively Reduces Orb2A Oligomerization
(A) Stability of Orb2A and Orb2AF5Y in S2 cells is similar. Transfected cells were treated with cycloheximide 16 hr post-transfection, and aliquots were taken for
western blot (Ab273) at the indicated times.
(B) Steady-state levels of Orb2A and Orb2AF5Y are similar. Untagged Orb2A and Orb2AF5Y were cotransfected with EGFP. The EGFP serves as transfection and
loading control.
(C) FRAP analysis of the Orb2AEGFP and Orb2AF5YEGFP puncta. Fraction mobile ± SEM: Orb2A, 0.170 ± 0.012, n = 9; Orb2AF5Y, 0.533 ± 0.019, n = 8, p = 2.23
1011. See Extended Experimental Procedures for details. 20% recovery corresponds to diffuse component recovery. Data are represented as mean fold
increase ± SEM.
(D) FRET analysis of the EGFP- and mCherry-tagged Orb2A and Orb2AF5Y. In Orb2A+Orb2AF5Y, the Orb2A was tagged with EGFP, and Orb2AF5Y with mCherry.
FRET: mean ± SEM: Orb2A, 0.0636 ± 0.0056, n = 18; Orb2AF5Y, 0.0475 ± 0.0075, n = 18, p = 0.042; Orb2A+ Orb2AF5Y, 0.0283 ± 0.0073, n = 12, p = 8.43 105.
Data are represented as mean fold increase ± SEM.
(E) A representative blot of SDS-resistant oligomers formed by recombinant Orb2A and Orb2AF5Y. After indicates extent of oligomerization following removal of
the pre-existing oligomers.
(F) The monomeric Orb2A and Orb2AF5Y bound similarly to the 30 untranslated region (UTR) of Tequila mRNA. The oligomeric Orb2 was not detected in the
Orb2AF5Y lane; either the amount of Orb2AF5Y oligomer is low and/or the oligomeric Orb2AF5Y does not bindmRNA. The 30UTR of Actin88F and rutabaga controls
for nonspecific mRNA binding.
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wild-type rescue flies (Figure 7D and Table S1). This latent defect
in memory is in agreement with the male courtship suppression
results even though these tests utilize different training strate-
gies. The fact that the Orb2AF5Y mutation produces later defects
in memory than reductions in Orb2 proteins also highlights
the specificity of this modification and suggest that efficient
oligomerization of Orb2 is required for long-term memory
stabilization.
DISCUSSION
Previously, based on studies primarily with Aplysia CPEB, we
postulated that self-sustaining amyloidogenic oligomers, similar
to yeast prion-like proteins, might be the basis of the persis-
tence of activity-dependent increase in synaptic efficacy and
the persistence of memory (Heinrich and Lindquist, 2011;
Si et al., 2003b, 2010). However some of the earlier analysis
was performed under overexpression or in heterologous condi-
tions. Here we find that like other amyloids, in physiological
concentration, in the adult Drosophila brain, Orb2 forms tetra-
mers or hexamers that are resistant to heat, SDS, and chaot-
ropic reagents. Stimulation of behaviorally relevant neurons
increases the level of oligomeric Orb2, which is enriched in the
synaptic membrane fraction (Figures 2G and 2H). These obser-
vations suggest that the unusual amyloidogenic oligomerization
of Orb2/CPEB is conserved across species, and the oligomer
may indeed act to stabilize activity-dependent increase in
synaptic efficacy.
A Putative Model for Orb2-Dependent Long-Lasting
Memory
We find that a mutation in the rare Orb2A isoform that results
in reduced oligomerization, without lowering the amount of
Orb2B protein, produces a selective deficit in the stabilization
of memory beyond 24 hr (Figures 7C and 7D). This is different
than loss of both isoforms, which leads to earlier memory deficit
(Figures S6 and S7). One interpretation of these data is that
Orb2B activity is required for the formation of long-termmemory,
whereasOrb2A activity is required for the persistence ofmemory
beyond 24 hr. However, both Orb2A and Orb2B form amyloid-
like oligomers and when overexpressed in Dorb2/+ background
can rescue the male courtship suppression memory (Keleman
et al., 2007) as well as olfactory-reward memory at 24 hr, sug-
gesting functional similarity. How can these observations be
reconciled?
When expressed in S2 cells, both Orb2A and Orb2B act as
translation repressor (Mastushita-Sakai et al., 2010). In the adult
brain, the Orb2B protein is constitutively expressed in a large
number of neurons, but the Orb2A protein is 100-fold less
abundant, expressed in fewer neurons, and deletion of Orb2A
reduces overall Orb2 oligomerization in vivo. Together, these
results suggest the following model. Orb2B-mediated transla-(G) The monomeric forms of Orb2A and Orb2AF5Y showed similar binding to
protein Fne served as negative control. The total lysates were blotted with an
levels.
See also Figure S5.tion repression is critical for the formation and consolidation
of memory up to 24 hr, and when ectopically expressed,
Orb2A rescues this repressive function of Orb2B. However,
regulated conversion of Orb2 proteins to the oligomeric state
is necessary for long-term stabilization of memory beyond
24 hr, and the Orb2A protein regulates this conversion. This
model implies that Orb2A and Orb2B have nonredundant
functions in long-term memory, and neurons in which Orb2
oligomerizes are the site for long-term memory storage in
Drosophila.
The recent modENCODE project has reported four new
protein isoforms in the Orb2 locus that would be affected in
the Orb2 deletion mutants (Figure S1B). However, the Orb2 olig-
omers or the behavioral phenotypes observed here are not
dependent on these isoforms. The Orb2 antibodies used here
do not recognize the common region between Orb2B and the
new isoforms (Figure S4D). Moreover, Orb2A and Orb2B cDNA
as well as a genomic construct that does not code for any of
these new proteins isoforms can rescue behavioral deficit
(Figures 7 and S7). The function of these new isoforms has yet
to be determined.
A Plausible Mechanism for Regulation of Amyloid-like
Oligomerization of Orb2
Although the amyloidogenic forms of PrP (Prusiner, 1998) and
other proteins are pathogenic, it is now evident that amyloids
can underlie epigenetic heritable phenotypes in yeast (Alberti
et al., 2009; Wickner et al., 2008) and can serve normal physio-
logical functions in other organisms (Fowler et al., 2007; Hou
et al., 2011; Iconomidou and Hamodrakas, 2008; Maji et al.,
2009; Saupe, 2007). However, in most cases it is unclear how
amyloid formation is regulated, if at all. The low level of Orb2
oligomers in the adult brain and their virtual absence from the
body raise the possibility that although Orb2B protein is widely
expressed, Orb2 oligomerization per se is limited, perhaps only
in neurons in which Orb2A is expressed. The Orb2A protein,
due to its propensity to oligomerize, may form the seed that
recruits Orb2B protein, resulting in the temporally and spatially
restricted conversion of Orb2A/Orb2B into self-sustaining
oligomers. In this regard, Orb2 oligomerization may resemble
seeded formation of curli amyloid on the surface of bacteria,
in which oligomerization of the major curli subunit CsgA is
seeded by the membrane-bound minor subunit CsgB (Hammer
et al., 2007).
Curiously, we find that Orb2A mRNA in the adult brain
retains an intronic sequence with stop codons (Figure S4A).
Among age-matched pCasper-Orb2AEGFP flies, we observed
heterogeneity in the Orb2A protein level, particularly in the
synaptic-neuropil region (Figure 3D). The low abundance, pres-
ence of unprocessed mRNA, and immense propensity to
oligomerize imply that in the adult head, expression of Orb2A
is regulated and may constitute the rate-limiting step in Orb2the FLAG-tagged CG13928, Squid, and Smaug proteins. The RNA-binding
ti-FLAG (W: FLAG) or anti-Orb2 (W: Orb2) antibodies to check expression
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Figure 7. The Orb2AF5Y Mutants Are Defective in Forming Long-Lasting Memory
(A) Orb2AF5Y mutation does not alter the level of Orb2B protein. Indicated amount of total head extracts blotted for Orb2 or for tubulin as loading control.
(B) Orb2AF5Y mutation reduces activity-dependent oligomer formation in the adult brain. Representative immuno-western is shown in the left panel. Right panel
shows quantification of blots expressed as fold change in oligomer compared to unstimulated brain; Wild-type Orb2A, 2 hr, 5.56 ± 1.5; Orb2AF5Y, 2 hr, 1.19 ±
0.24, n = 6, p = 0.005; t test. Wild-type Orb2A, 4 hr, 4.8 ± 1.8; Orb2AF5Y, 4 hr, 1.8 ± 0.5, n = 6, p = 0.076. Data are represented as mean ± SEM.
(C) The Orb2AF5Y mutant males are defective in forming stable courtship suppression memory that persists beyond 48 hr.
(D) The Orb2AF5Y mutant flies are impaired in forming stable associative olfactory-reward memory persisting for 48 hr. Data are represented as mean ± SEM.
Please see Table S1 for the memory index values. See also Figures S6 and S7 and Tables S1, S2, and S3.oligomerization and thereby long-lasting memory formation.
Moreover, although Orb2A mRNA is present in the body (Si
et al., 2003a), the Orb2A protein was undetectable, suggesting
that it is present either in very low levels or only in certain cell
types. What function Orb2A serves outside the nervous system
is not known.526 Cell 148, 515–529, February 3, 2012 ª2012 Elsevier Inc.Functional Amyloid
It is now evident that a number of proteins with very different
primary amino acid sequences can form self-templating
amyloids (Toyama and Weissman, 2011). What sequence and
structural features distinguish a regulated functional amyloid
from unregulated inactive or pathogenic amyloids? Although
these studies were initiated with the observation that Aplysia
CPEB contains a Q-rich unstructured domain, we find that
the Q-rich region of Orb2 is important for the stability but not
formation of oligomer. Similarly, a coiled-coil domain outside
the amyloid-forming domain of Aplysia CPEB regulates its oligo-
merization (Fiumara et al., 2010). These observations suggest
that identification of functional amyloid based on primary amino
acid sequence is challenging. Highlighting this point, we found
that a single nonpolar to polar amino acid change in the
N-terminal 8 amino acids of Orb2A affects not only the efficiency
of oligomerization but also the nature of the amyloid oligomer.
Structural analysis of wild-type and mutant Orb2 proteins may
help us to understand what features distinguish functional
amyloid from nonfunctional amyloid.EXPERIMENTAL PROCEDURES
Drosophila Strains and Antibodies
Please see Extended Experimental Procedures for details of fly strains and
antibodies used in this paper.Fly Synaptosome
Fly synaptosome purification is based on the protocols used inmouse,Aplsyia,
and Drosophilamembrane preparation (Chin et al., 1989; Ehlers, 2003; Venka-
tesh et al., 1980). All Sucrose solutions were made in Buffer A (10 mM Tris-HCl
[pH 7.5]). Tyramine-stimulated adult fly heads were crushed in 0.32 M sucrose
buffer (2 ml/0.5 gm of head) and centrifuged twice at 1000 3 g for 20 min to
separate the nucleus and other heavier cellular components from the
membrane and soluble proteins. The supernatant (T) was centrifuged at
15,000 3 g for 15 min, and the resulting pellet was resuspended and centri-
fuged again 15,0003 g for 10 min to obtain washed crude synaptosome frac-
tion (P1). The P1 fraction was resuspended in 0.32 M sucrose buffer, and 1 ml
of the resupended pellet was loaded on top of a 9.9 ml 0.5 M, 0.8 M, and 1.2 M
sucrose buffer step gradient and centrifuged at 100,0003 g for 3 hr in a Beck-
man SW40 rotor. The interface between 0.8 and 1.2 M sucrose was collected,
diluted to 8ml with 0.32M sucrose, loaded on top of 4ml 0.8M sucrose buffer,
and centrifuged at 230,000 3 g for 22 min in SW40 rotor to obtain purified
synaptosome (P2). The pellet was extracted with 1% NP40 and 1% Triton
X-100, 10 mM Tris-HCl (pH 7.5) buffer. The resuspended pellet was centri-
fuged 15,0003 g for 15min, and the supernatant was used as soluble synaptic
fraction. The pellet containing purified synaptic membrane was extracted with
buffer containing 1% NP40, 1% Triton X-100, and 1% SDS, 10 mM Tris-HCl
(pH 7.5) (P3).Western Blot and Immunoprecipitation
For western blot analysis, fly heads were homogenized (2–4 ml of buffer/head)
in a PBS buffer containing 150 mM NaCl, 3 mM MgCl2, 0.1 mM CaCl2, 5%
glycerol,1% Triton X-100, 1% NP40, and protease inhibitors (Roche), and
approximately 5–10 head equivalents of extract were used. For the immuno-
precipitation, 1.5–2 mg of total protein was incubated with 0.5 to 1 mg of the
purified antibodies for 2 hr at 4C and protein-A beads (Repligen) for an
additional 2 hr. For immunoprecipitation of Orb2AEGFP, 8 mg of total head
extracts was incubated with either anti-Orb2 antibody 2233 or chromotek-
GFP-Trap beads (Allele Biotech). For the Orb2A and Orb2B interaction exper-
iment, Orb2B was immunoprecipitated with anti-HA antibodies and western
blotted with anti-EGFP antibodies. Please see Extended Experimental Proce-
dures for detail.RNA Pull-Down Experiment
The RNA pull-down experiment from S2 cells was performed as described
previously (Mastushita-Sakai et al., 2010).Feeding of Drosophila
Two- to four-day-old adult flies were starved for 12–16 hr and later transferred
to vials containing either only 2% sucrose or 2% sucrose and the neurotrans-
mitter. At indicated times, the flies were quickly frozen in liquid nitrogen,
the heads were isolated, and total head extracts were prepared for immuno-
precipitation. For stimulation with dTrpA1 channel, the flies were raised and
housed in a 22C incubator and transferred to 28C for indicated time period.
Gradient Analysis
For the sucrose gradient analysis, tyramine-stimulated fly headswere isolated,
and Orb2 was immunoprecipitated with Ab2233 from 10 mg of total head
extracts (500 heads). The immunoprecipitate was eluted from protein-A
agarose beads using 0.1 M glycine-HCl buffer (pH 3.0) and immediately
neutralized by adding 1 M Tris-HCl (pH 8.0). The salt concentration was
adjusted to 500 mM KCl, and 100 ml of the immunopurified Orb2 was loaded
onto a 4 ml linear 5%–30% sucrose (w/v) gradient prepared in a gradient
buffer containing 50 mM Tris-HCl (pH 7.5) and 500 mM NaCl. The gradient
was centrifuged at 50,000 rpm for 4 hr at 4C in a SW60Ti rotor, and 24 frac-
tions of150 ml were collected. These fractions were immunoprecipitatedwith
cold TCA in a final concentration of 15%, washed with cold acetone, loaded
onto a 4%–12% SDS-PAGE Bis-Tris gradient gel (Invitrogen), and analyzed
by western blot using an Orb2-specific antibody (1:1000 Ab273). Representa-
tive molecular weights were determined by fractionating similar gradients
loaded with 50 mg of the following standards, BSA (67 kDa), Aldolase
(150 kDa), and thyroglobin (670 kDa).
Orb2A Mutant Screening
The Orb2A mutant library was made with site-directed mutagenesis. Please
see Extended Experimental Procedures for details. Individual clones were
transfected in S2 cells and visualized under a microscope to screen for
diffused cytoplasmic GFP pattern.
Male Courtship Suppression Assay and Appetitive-Olfactory
Conditioning
For courtship conditioning, amodified version of the spaced training described
by McBride and colleagues (McBride et al., 1999) was used. The olfactory-
appetitive conditioning paradigm was performed as described previously by
Krashes and Waddell (2008).
GraphPad Prism version 4.0 for Windows (GraphPad software, San Diego,
CA, USA) was used to carry out statistical analysis on all the behavioral
data. For all experiments, we assumed statistical significance at p < 0.05.
One-way ANOVA was used for comparing performance of wild-type and
mutant flies for each measurement during acquisition and memory test. Tukey
multiple tests were performed when significance was reached (p < 0.05) in the
ANOVAs. Unless stated otherwise, for all experiments n is R 8. Please see
Extended Experimental Procedures for detail.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
seven figures, and three tables and can be found with this article online at
doi:10.1016/j.cell.2012.01.004.
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